BridgeMD
New treatment option for Diabetes Mellitus Patients With Kidney Transplantation
Official title Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial
ClinicalTrials.gov ID: NCT06962410
What this study is testing
- What it's testing
- Objective: To evaluate the short-term blood glucose control effect of the closed-loop system combined with a regular insulin pump and continuous glucose monitoring (CGM) in hospitalized patients with diabetes after kidney transplantation, explore its clinical application value, and provide precise and personalized blood glucose management plans. Methods: A clinical comparative study will be conducted.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Aged 18 - 70 years;
- Meets the diagnostic criteria in the "Guidelines for Prevention and Control of Diabetes in China (2024 Edition)": A patient can be diagnosed with...
- Able to correctly use insulin pumps and CGM devices, and has certain learning and operational abilities;
- Agrees to participate in the study and signs the informed consent form.
You likely can't join if
- The patient has experienced acute diabetic complications within the past month, such as diabetic ketoacidosis, hyperglycemic hyperosmolar coma, etc.
- The patient has severe symptoms of hypoglycemic intolerance.
- The patient has skin diseases such as rashes and prurigo, or abnormal coagulation function.
- The patient has diseases related to glucose metabolism, such as uncontrolled hyperthyroidism, uncontrolled hypothyroidism, Cushing's syndrome, etc.
- The patient has severe diseases of the liver, kidneys, gastrointestinal tract, hematopoietic system, brain, circulatory system, etc.
- Patients with malignant tumors (including solid tumors and hematological malignancies).
See the full eligibility criteria
- Aged 18 - 70 years;
- Meets the diagnostic criteria in the "Guidelines for Prevention and Control of Diabetes in China (2024 Edition)": A patient can be diagnosed with diabetes if he/she presents typical symptoms of diabetes (including...
- Able to correctly use insulin pumps and CGM devices, and has certain learning and operational abilities;
- Agrees to participate in the study and signs the informed consent form.
- The patient has experienced acute diabetic complications within the past month, such as diabetic ketoacidosis, hyperglycemic hyperosmolar coma, etc.
- The patient has severe symptoms of hypoglycemic intolerance.
- The patient has skin diseases such as rashes and prurigo, or abnormal coagulation function.
- The patient has diseases related to glucose metabolism, such as uncontrolled hyperthyroidism, uncontrolled hypothyroidism, Cushing's syndrome, etc.
- The patient has severe diseases of the liver, kidneys, gastrointestinal tract, hematopoietic system, brain, circulatory system, etc.
- Patients with malignant tumors (including solid tumors and hematological malignancies).
- The patient has impaired consciousness or mental illness, lacks self-control, and is unable to express clearly.
- Lactating women, pregnant women, or women who plan to become pregnant during the trial period.
- The patient is allergic to the drugs involved in the clinical diagnosis and treatment plan.
- The patient is currently using other closed-loop systems.
- Populations not suitable for conventional insulin pump therapy and contraindications.
- The patient has known or suspected insulin allergy, or is allergic to adhesive tape, insulin pumps, or CGM devices.
- Other situations where the investigator deems the patient unfit to participate in the clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Taiyuan, Shanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taiyuan, Shanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.